FDA label
What is lidocaine used for?
The FDA-approved uses of lidocaine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted lidocaine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lidocaine Hydrochloride, injection, solution
Indications and Usage, quoted from the label by Hospira, Inc. (ANDA040302). Cross-references to other label sections are left out.
Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.
Source: DailyMed label, set id ad1ef0a8-88db-4648-c098-d009eaeb4e5b, version 32, effective August 20, 2026. NDC 0409-1323, one of 138 listings for this product.
Lidocaine, ointment
Indications and Usage, quoted from the label by Amneal Pharmaceuticals LLC (ANDA206297). Cross-references to other label sections are left out.
Lidocaine Ointment 5% is indicated for production of anesthesia of accessible mucous membranes of the oropharynx.
It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites.
Source: DailyMed label, set id 960f6d0a-82af-45e9-89d5-cea808004ebb, version 11, effective August 25, 2026. NDC 65162-918, one of 70 listings for this product.
Lidocaine Hydrochloride, solution
Indications and Usage, quoted from the label by Brookfield Pharmaceuticals, LLC. (ANDA212821). Cross-references to other label sections are left out.
Lidocaine Hydrochloride Injection, USP is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of
Source: DailyMed label, set id e824ba5b-3289-5ad4-e053-2995a90acc20, version 5, effective November 27, 2025. NDC 71351-021, one of 44 listings for this product.
Questions
What is lidocaine used for?
The FDA label says: “Lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.”
What drug class is lidocaine?
FDA lists lidocaine in the Amide Local Anesthetic and Antiarrhythmic established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Lidocaine
- Is Lidocaine a controlled substance?Federal schedule
- Generic for XylocaineFDA Orange Book
- Generic for AktenFDA Orange Book
- Generic for Xylocaine DentalFDA Orange Book
- Generic for Xylocaine Preservative FreeFDA Orange Book
- Generic for LidodermFDA Orange Book
- Generic for ZtlidoFDA Orange Book
- Generic for Xylocaine ViscousFDA Orange Book
- Generic for BondlidoFDA Orange Book
- What is Ztlido used for?FDA label uses
- Is Ztlido a controlled substance?Federal schedule
- Amide Local Anesthetics listFDA drug class
- Antiarrhythmics listFDA drug class
- NDC 0338-0409Lidocaine NDC record
- NDC 0338-0411Lidocaine NDC record
- NDC 0404-9973Lidocaine NDC record